| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Mar 09, 2026 |
uniQure N.V.
QURE
|
BUY |
$60.00
Est. +239%
|
$17.69 | $50.08 |
Pending
|
$46.29
+161.7%
|
| Jan 20, 2026 |
RAPT Therapeutics Inc
RAPT
|
BUY |
$58.00
Est. +1%
|
$57.50 | $58.02 |
Bullseye Hit (±1%)
|
$58.01
+0.9%
|
| Oct 13, 2025 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$75.00
Est. +3%
|
$73.10 | $75.16 |
Bullseye Hit (±1%)
|
$54.09
-26.0%
|
| Aug 22, 2025 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$82.00
Est. +92%
|
$42.69 | $86.74 |
Target Met
|
$74.12
+73.6%
|
| Jun 17, 2025 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$75.00
Est. +248%
|
$21.56 | $25.32 |
Miss
|
$17.53
-18.7%
|
| Mar 12, 2025 |
Voyager Therapeutics Inc
VYGR
|
BUY |
$10.00
Est. +162%
|
$3.81 | $5.55 |
Miss
|
$3.72
-2.4%
|
| Dec 31, 2024 |
Sangamo Therapeutics Inc
SGMO
|
BUY |
$2.00
Est. +96%
|
$1.02 | $1.45 |
Miss
|
$0.17
-83.3%
|
| Oct 23, 2024 |
Editas Medicine Inc
EDIT
|
BUY |
$9.00
Est. +174%
|
$3.29 | $4.54 |
Miss
|
$2.69
-18.2%
|
| Oct 15, 2024 |
Spyre Therapeutics Inc.
SYRE
|
BUY |
$40.00
Est. +30%
|
$30.66 | $40.26 |
Bullseye Hit (±1%)
|
$88.34
+188.1%
|
| Jun 12, 2024 |
Avidity Biosciences Inc
RNA
|
BUY |
$50.00
Est. +73%
|
$28.92 | $55.98 |
Target Met
|
$12.66
-56.2%
|
| May 20, 2024 |
Autolus Therapeutics plc - ADR
AUTL
|
BUY |
$8.00
Est. +82%
|
$4.39 | $5.00 |
Miss
|
$1.51
-65.6%
|
| Jan 07, 2022 |
CRISPR Therapeutics AG
CRSP
|
BUY |
$105.00
Est. +55%
|
$67.66 | - | - |
$54.09
-20.1%
|
| Jan 07, 2022 |
Global Blood Therapeutics Inc.
GBT
|
BUY |
$70.00
Est. +144%
|
$28.63 | $68.49 |
Precision Hit (±3%)
|
$68.49
+139.2%
|
| Jan 07, 2022 |
uniQure N.V.
QURE
|
BUY |
$34.00
Est. +74%
|
$19.50 | - | - |
$46.29
+137.4%
|